los con las del por una para pacientes como más son virus infección tratamiento enfermedad puede casos sin ser entre han este riesgo pueden diagnóstico mayor esta paciente infecciones sobre también durante neumonía estos forma debe caso aunque años otros estudios síntomas está pero hasta niños días influenza enfermedades uso dos muy clínica tanto estudio presencia embargo frecuencia cuando pulmonar epoc salud menos nac datos otras células tienen desde frecuente resultados mediante mortalidad muestras importante todo hay todos así aguda factores estas cada además respuesta grave mayoría general respiratorias tabla algunos respiratoria personas edad frente sus fiebre tipo aumento viral 
disease lesions cells signs tissue common small cases clinical blood occur normal include liver present diagnosis fig dogs animals intestinal fluid skin severe affected occurs chronic infection large result cell cats acute examination mucosa necrosis loss epithelium tissues inflammation body rabbits caused intestine horses commonly epithelial tract reported form hepatic inflammatory diarrhea secondary develop species lymph bone edema increased gastric abdominal treatment nasal including similar primary pulmonary found renal tumors lesion areas surface mucosal muscle ferrets diseases mild systemic characterized damage type syndrome presence important lung rare nodes occasionally colon oral heart frequently typically condition e.g glands obstruction gastrointestinal wall 
vaccine vaccines antibody virus antibodies mice immune responses vaccination response antigen igg neutralizing protection immunization challenge immunity antigens epitopes protein serum infection recombinant titers immunized vaccinated animals group dna protective influenza dose viral epitope specific neutralization development efficacy sera studies days induced groups shown effective high mucosal animal iga induce clinical adjuvant human strain inactivated study developed vector attenuated immunogenicity weeks live mabs day antigenic levels humoral vlps administration strains higher administered titer hiv vectors doses disease showed control viruses results proteins injection based expressing safety compared demonstrated production oral elisa tested cell humans model significant potential produced route mouse 
samples detection pcr assay positive dna sample rna assays virus results viral sensitivity test detected amplification clinical rt-pcr reaction methods negative primers diagnostic testing specimens viruses performed method detect tests real-time tested primer nucleic specificity laboratory table diagnosis probe specific probes molecular min target analysis kit study control rapid acid culture time standard obtained collected gene extraction sensitive high sequencing pathogens developed system laboratories based blood multiplex reverse number human sequences hybridization products sequence identification serum reference single low polymerase total specimen conventional compared amplified designed diagnostics extracted presence copies antigen including result values applied lamp microarray protocol detecting reactions 
health care patients study hospital patient medical risk data control sars outbreak infection cases staff healthcare information participants hospitals disease reported emergency public workers studies training contact transmission measures time surveillance clinical pandemic case number infectious covid including system intervention table prevention symptoms included isolation response work nurses respiratory review knowledge management exposure support survey high outbreaks community practice group research provide hand based guidelines level procedures general results influenza period people diseases conducted potential laboratory facilities treatment factors identified important significant provided education illness hcws personal screening students equipment cdc testing personnel individual physicians analysis hygiene required department family 
data analysis genes sequences sequence gene table number genome figure set based species sequencing identified study information genetic methods fig database selection reads results genomes method human found analyses model regions diversity phylogenetic tree selected values total reference related group samples evolutionary evolution identify multiple length protein variation studies predicted host variants high approach single sites significant genomic amino cluster similar prediction differences viral performed compared groups alignment algorithm nucleotide region viruses obtained supplementary sample shown search network similarity mutations dataset additional present time size generated sets observed score level large acid test order clusters classification common frequency codon included 
der die und bei von mit eine ist werden den sind für einer oder des das auch nicht durch als auf zur nach ein sich wird kann patienten dem aus können vor nur therapie dass über einem sie wie bis sowie keine diese aber unter wurde zum einen sollte eines bzw infektionen muss wurden infektion sein gegen wenn jedoch noch man hat beim sehr dieser haben erreger zwischen behandlung während schwangerschaft tab anderen meist ohne anwendung müssen aufgrund insbesondere mehr häufig möglich sollten studien kap besteht kommt abb nachweis alle eingesetzt erfolgt vom gibt erkrankung risiko auftreten erkrankungen z.b jahren 
sars-cov mers-cov sars coronavirus van cov ace mers coronaviruses een respiratory rbd spike het camels dpp hcov covs human saudi ncov arabia met hku camel bij syndrome middle east hcov-nl receptor hcov-oc hajj pilgrims severe zijn acute bat china dromedary voor patients cases door outbreak die worden orf infection ook dat kan wordt betacoronavirus als nucleocapsid humans wuhan entry tot confirmed aan niet deze pneumonia arabian virus epidemic hcov-hku hdpp covid transmission civet sars-cov-infected ksa bats dromedaries protein kunnen tract hcovs contact dit civets vero reported peninsula hong kong dan remdesivir guangdong chinese qatar mild hcov-emc pathogenesis urbani identified anti-sars-cov 
virus cells viral proteins membrane cell protein viruses fusion hiv entry host surface infection receptor particles binding replication ifitm cellular membranes shown envelope virions lipid hcv golgi receptors formation influenza plasma glycoproteins acid found studies infected glycoprotein vesicles domain role human transport interaction complex required assembly virion intracellular specific form fig release process capsid structures attachment sialic pathway cleavage important similar cytoplasmic type involved addition transmembrane activity function budding cholesterol interactions mechanism presence bind enveloped glycosylation present glycans acids infectivity target endocytosis site cytoplasm secretory env structural sites amino domains including endosomal early observed particle ebov family molecules endosomes microscopy 
respiratory influenza children infection study virus viral viruses patients infections rsv age studies years symptoms cases asthma pneumonia clinical disease illness tract acute severe detected data common lower reported found adults days nasal group table infants hrv hmpv human positive months risk rhinovirus samples compared year significant cough identified higher severity hbov groups rate detection hospital upper subjects seasonal bacterial specimens pathogens bronchiolitis population including period similar rates hospitalized number wheezing adenovirus young incidence included prevalence analysis high fever airway observed increased exacerbations aged pandemic season piv parainfluenza association factors nasopharyngeal shown findings significantly due older hospitalization previous cold results 
surface nanoparticles work particles solution detection method fig size high concentration fluorescence form time due properties based applications figure nps membrane system signal molecules imaging particle information section methods dna images mass light process sample temperature water range lipid materials chemical technique image low layer reported analysis shown intensity gold applied electron area small higher magnetic study present sensor ions flow target fluorescent techniques systems aptamers ion structure polymer developed biological increase formation aptamer groups obtained diameter interactions field phase metal potential conditions binding optical acid devices measurements results compared provide submitted observed silver ratio microscopy application liposomes separation addition 
les des une est dans par sont pour avec sur chez qui d'une cas être pas ces peut ont d'un été cette traitement aux mais comme patients virus entre après deux ans diagnostic elle peuvent leur souvent maladie fait risque l'enfant très moins mois sans aussi doit enfants son ainsi même n'est cours cellules clinique jours soit dont plusieurs bien pendant syndrome vers lors niveau infections était avant présence recherche sous également respiratoire signes lésions elles permet alors trois forme type tout prise d'autres donc peu respiratoires selon nombre patient ils facteurs contre notamment partie études autres chronique certains charge 
model preprint number data cases time epidemic rate population models transmission license disease case covid infected individuals copyright medrxiv holder author/funder peer-reviewed figure infection https://doi.org outbreak period fig results doi infectious distribution probability parameters network days display made values granted contact international perpetuity analysis table study based estimated spread control average estimates total individual estimate size dynamics china effect i.e reported rates day observed parameter measures system susceptible information spatial function variables higher biorxiv due shown growth incidence initial confirmed large high set peak infections people countries wuhan contacts shows state networks level scenario cc-by-nc-nd social method assumed effects interval 
mice brain cns cells rats disease neurons mouse rat spinal csf microglia astrocytes demyelination cell myelin cord studies neuronal animals lesions eae mhv found system tissue increased observed results model days nervous encephalitis role present nerve autoimmune patients neurological study normal inflammatory levels expression matter brains clinical virus multiple antibodies showed central effects experimental induced acute chronic evidence peripheral demyelinating sclerosis oligodendrocytes loss injury glial effect day number white neural specific similar cerebral axonal models disorders muscle shown protein detected response damage animal motor suggest compared injection adult encephalomyelitis development microglial weeks bbb sections primary controls cortex increase time diseases 
rna viral virus nsp replication viruses genome sequence protein mrna translation orf synthesis proteins dna sequences rnas fig gene region transcription polymerase site structure mutations end host mrnas genomic figure codon shown mutant nucleotide nucleotides genomes activity conserved rdrp sites vitro initiation mhv mutation recombination strand frameshifting cellular mutants cells similar structural genes template complex utr found transcripts required cleavage infected presence regions cdna structures trna hcv mechanism amino ribosomal downstream frame helicase dsrna products subgenomic role domain expression base function observed ribosome elements frameshift reverse studies pol replicase coding efficiency position cap orfs present results reading addition coronavirus motif 
air water temperature exposure food environmental particles concentration infl environment time room airborne ventilation conditions high flow system study contamination fig rate studies aerosol pressure surfaces surface uenza source building risk area size wind found higher contaminated shown particle transmission concentrations results heat low filter bacteria process level due indoor test table systems sampling waste method respiratory droplets effects large rst total pathogens lower control humidity cleaning removal energy levels gas efficiency disinfection infectious effect materials chemical signifi volume e.g human aerosols pollution specifi increased inactivation quality number transport microorganisms treatment methods material viruses reduce increase buildings important equipment areas 
activity compounds antiviral acid compound drug inhibition effects inhibitors effect treatment showed drugs group reported active concentration activities found concentrations inhibitor inhibitory reaction derivatives extract inhibit potent vitro synthesis table cell action effective studies shown plant human inhibited potential extracts study enzyme addition results agents isolated properties mixture obtained ribavirin values groups virus natural chemical added toxicity tested assay plants solution high mmol products fig hbv hiv yield including mechanism water significant reduced liver cytotoxicity acids treated reduction zinc presence cells growth exhibited species combination due evaluated synthesized cancer antioxidant product hsv ring enzymes compared analogues hcv dose observed therapeutic 
protein expression proteins activation signaling cells pathway activity cell response ifn genes infection ace role gene apoptosis cellular viral pathways phosphorylation transcription host levels nuclear irf stress kinase degradation involved factor function shown binding type antiviral dna regulation replication isg human including inhibition induction induced ang complex rig-i mir mrna studies stat factors immune interaction identified increased functions found important domain family production receptor caspase innate mitochondrial mechanisms target mechanism rna expressed nf-κb figure inhibitor eif cycle mediated addition effects activated death promoter study nucleus induce inhibit mda results reported control transcriptional trim cancer ubiquitin inhibitors specific regulated induces responses 
health public countries research global international disease national information development diseases people social system world risk china systems government economic management response states services policy local important human data resources years including security community time level work tourism control access support population state impact provide medical process issues approach country areas change major market media disaster million capacity chinese scientific surveillance industry science infectious developing united food regional crisis knowledge future political key activities events life developed role include potential efforts year risks part make made number based urban increase service factors costs problems communication focus organizations organization challenges programs 
cells immune mice cell infection response expression responses macrophages cytokines production activation lung inflammatory levels tlr role cytokine viral human increased type inflammation studies disease receptor innate ifn virus shown epithelial infected lymphocytes receptors infections tissue function blood host mechanisms induced immunity important dcs system antigen found specific including vivo molecules induction signaling cxcl activated mouse model lps effects expressed neutrophils vitro development t-cell monocytes stimulation induce compared mhc observed demonstrated factor addition high pathogenesis reduced ccl tissues lungs adaptive increase acute significantly activity effector chronic class chemokines surface ifn-γ ccr proliferation peripheral models dendritic results memory damage clearance endothelial 
infection infections bacterial bacteria patients disease treatment resistance pathogens antibiotic antibiotics clinical antimicrobial strains pneumonia therapy risk cases agents hiv organisms isolates common pneumoniae infectious culture aureus coli diagnosis tuberculosis include blood cmv resistant children pathogen including infants hepatitis fever caused acute species days important mrsa cultures oral spp high incidence due organism tract microbial diseases fungal recipients factors found patient specific isolated colonization susceptibility agent respiratory studies diarrhea chronic mortality results years present presence salmonella occur aeruginosa women viral microorganisms effective gram-negative reported cap infected recommended testing rates transplant symptoms considered recent identified streptococcus increased staphylococcus toxin severe drug 
cats calves animals dogs study disease days cattle infection milk age animal samples diarrhea group clinical feline cat serum calf control fip signs weeks time fecal day found bovine period treatment infected groups table cows reported canine significant studies herds test veterinary high positive results colostrum higher pigs observed blood herd feed prevalence farms increased number dairy compared healthy farm present fed concentrations weight dog feeding months low bvdv feces total production considered levels spp effect fiv differences significantly diarrhoea factors shedding risk collected status presence due antibodies birth infections felv mortality coli negative species horses included diet sheep intestinal 
cells fig cell infection virus infected figure viral control expression data observed performed assay incubated results medium min mice compared pbs treated previously levels culture replication analysis days day shown experiments treatment determined effect significantly study significant showed time analyzed rna usa total vero measured antibody washed detected plates added mouse group staining collected fold cultures samples activity serum transfected stained determine titers obtained human hours times moi incubation level p.i previous test increased cultured concentration lines fixed luciferase reduced similar tissue buffer kit plaque presence primary line higher supernatants hpi experiment examined number software concentrations groups harvested inhibition transfection 
cell cells human gene development expression dna target cancer studies drug potential protein approach proteins delivery system therapeutic clinical specific systems sirna production genes tumor genetic research diseases approaches disease targeting vivo treatment developed viral drugs hiv therapy targets models molecular including high effective important host process biological agents molecules small growth complex cellular recently vectors effects large recent targeted number vitro technology e.g strategies based trials strategy resistance biology discovery tissue provide methods major design highly efficacy include types multiple animal model single application selection plants plant ability interactions understanding synthetic genome sirnas rnai screening applications due techniques lines 
patients treatment study clinical patient group lung disease therapy severe results blood days acute risk studies pulmonary levels increased significant mortality compared diagnosis day data symptoms years respiratory higher showed cases performed age time serum reported failure rate significantly pneumonia analysis chest high hospital chronic groups test lower treated findings function normal heart icu included level found admission total including positive cardiac dose subjects early syndrome outcome months covid received case due ventilation severity ards median asthma increase score injury care copd history factors table outcomes medical trial renal criteria plasma effects airway pressure oxygen evidence trials methods decreased onset 
binding residues structure protein domain peptide fig site structures proteins figure peptides structural amino pro interactions complex activity residue domains sequence interaction protease model shown region acid substrate active data crystal form conformation enzyme loop affinity observed hydrophobic similar catalytic molecular conserved sites molecules cleavage acids chain position conformational surface table c-terminal n-terminal energy proteases group ligand found fold bound side helix bond molecule motif bind inhibitors hydrogen regions results studies formation pdb function docking based determined state nmr receptor pocket predicted core analysis complexes inhibitor chains cys cysteine important bonds performed specificity class forms mutations dimer small high mutant 
virus disease viruses human species transmission infection humans host infected animals animal diseases cases bats viral infections infectious spread bat outbreaks pathogens hosts population fever influenza reported populations wild outbreak zoonotic dengue including avian potential high africa pathogen areas birds risk found emerging world contact studies countries transmitted emergence important natural years rabies poultry recent caused reservoir wildlife severe health surveillance control individuals identified evidence case endemic zikv asia ebola related due malaria highly range isolated occur exposure genetic domestic infect hev large family europe number epidemic occurred e.g african mortality factors pathogenic people west united major common regions south 
protein proteins fig cells antibody min buffer antibodies purified binding recombinant expression incubated serum analysis kda elisa shown expressed gel cell mab igg added plasmid results obtained performed fusion pbs activity amino sequence specific peptide data detected washed sera western human vector membrane previously samples assay medium analyzed peptides coli sds-page control concentration purification fragment acid gene plates clones presence monoclonal dna column showed temperature times incubation fragments mabs blot reaction determined antigen identified system fractions diluted centrifugation prepared molecular region mass room cloned total rabbit sample affinity pcr supernatant study culture fraction nacl lane overnight experiments band high present 
strains virus strain pedv ibv pigs gene viruses prrsv sequences study group tgev sequence isolates samples detected porcine viral showed genome orf chickens acid amino protein rna piglets swine isolated china analysis infection nucleotide infected table fig coronavirus observed reported phylogenetic found type chicken inoculated diarrhea birds rotavirus pcv pig region coronaviruses respiratory genes rt-pcr collected identified based groups positive pcr identity disease isolate enteric similar usa related genetic high clinical genbank present shown recombination gastroenteritis previously including field pdcov dpi genotype intestinal performed avian studies obtained primers compared tissue complete virulent min results genotypes signs fecal tissues spike ndv 
blood autophagy atg transfusion donors donor plasma platelet con red autophagic del platelets della che units rbc autophagosomes dei products tion donation delle una autophagosome sono beclin rbcs transfusions nel transfused donations storage components antibodies screening recipient ing bone iron hemoglobin alla product process gli recipients tra macroautophagy design/method antibody due reactions più testing bank gfp-lc flux rhd background/case abo safety degli salute saon antigens antigen inactivation apheresis results/finding supply collection hcv nat stato hemolysis anemia bees concentrates nei nella unit ulk typing plt rischio stati coagulation hla studio cell stored rapamycin lysosomes sqstm bleeding tions bee hanno pro puncta 
